Drugs & Clinical Trials | By July 23, 2006 | By Shaheen E Lakhan, MS, MEd, PhDcloseShaheen E Lakhan, MS, MEd, PhD Name: Shaheen Lakhan
Site: http://slakhan.gnif.org
See All Articles by Author (106)
About: Dr. Lakhan is the Executive Director of the Global Neuroscience Initiative Foundation (GNIF). He administers a host of projects in bioethics, biotechnology, emergency management, global philanthropy, proteomics, and psychiatry -- to name a few disciplines. | 4 Comments

Researching Drug Interventions in Bipolar Offspring: Current Ongoing Research

Last August, at the Stanford University Medical Center, Packard Research findings reported additional research on drug therapy for juveniles predisposed to bipolar disorder. They had found that children with psychiatric problems - who appear to be at high risk for bipolar disorder - already had done well on a mood-stabilizing drug. This was landmark research, in that it was the first study to examine youngsters apparently predisposed to contracting bipolar disorder. Read more →